Genomic sequencing of HRS cells and ctDNA from patients with cHL have identified loss-of-function alterations in B2M, a subunit on MHC class I, in 33-70% of cHL cases (15, 18, 19). The gene discussed is B2M; the disease is classic Hodgkin lymphoma.